Degradation of proteins by PROTACs and other strategies
Yang Wang(Babraham Institute), Haopeng Sun(China Pharmaceutical University), Xueyang Jiang(China Pharmaceutical University), Feng Feng(Nanjing Medical University), Wenyuan Liu(China Pharmaceutical University)
Cited by 312
Related Papers
Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease
|European Journal of Medicinal Chemistry|2017|307
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
|Journal of Medicinal Chemistry|2019|270
Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease
|European Journal of Medicinal Chemistry|2018|200
Strategies for Structural Modification of Small Molecules to Improve Blood–Brain Barrier Penetration: A Recent Perspective
|Journal of Medicinal Chemistry|2021|196
Triazoles in Medicinal Chemistry: Physicochemical Properties, Bioisosterism, and Application
|Journal of Medicinal Chemistry|2024|173